ddhCTP

1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

ddhCTP is an endogenously produced pyrimidine base analog with a Kd of 17.0 nM for LLDH and an IC50 of 55.8 μM for GAPDH. By inhibiting key metabolic enzymes such as GAPDH, ddhCTP reduces glycolytic flux and shifts metabolic flow toward the pentose phosphate pathway, thereby regulating the redox balance of cells. As a competitive CTP analog, ddhCTP terminates RNA synthesis by flavivirus RdRps and SARS-CoV-2 RdRp, and inhibits Zika virus replication in vivo. ddhCTP can be used in studies related to viral infections, COVID-19 and Zika virus infections.

For research use only. We do not sell to patients.

  • CAS No.: 2279171-34-3
  • Formula: C9H14N3O13P3
  • Molecular Weight:465.14
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) ddhCTP

More

All Endogenous Metabolite Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00